ISTH 2026 preview highlighting competitive developments in hemophilia, von Willebrand disease, anticoagulation and AI diagnostics.

ISTH 2026 Preview: Hemophilia, VWD and Anticoagulation Market Trends

ISTH 2026 at a glance ISTH 2026 brings emerging competitive dynamics into focus…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million

Lucid Diligence Brief: Agilent acquires Biocare Medical for $950 million…


Privacy Preference Center